"Ein einheitliches Krankenhaus mit 375 Betten, verteilt auf drei Klinikstandorte in Blaubeuren, Ehingen und Langenau. Das hat neben organisatorischer Straffung und wirtschaftlichen Überlegungen vor allem große Vorteile bei der Aus- und Weiterbildung von Ärzten sowie bei der Etablierung spezieller medizinischer Schwerpunkte für die Patienten. Langenau: Anästhesie, Chirurgie, Chirurgie/Phlebologie, Innere Medizin"

During the past decade, Kreiskrankenhaus Langenau conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kreiskrankenhaus Langenau" are "Arthritis, Rheumatoid" (1 trials), "Axial Spondyloarthritis" (1 trials), "Plaque Psoriasis" (1 trials), "Psoriatic Arthritis" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Kreiskrankenhaus Langenau" in a lesser frequency.

Most popular intervention types in "Kreiskrankenhaus Langenau" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Etanercept" (1 trials) and "Tofacitinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kreiskrankenhaus Langenau" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Kreiskrankenhaus Langenau". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Kreiskrankenhaus Langenau, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kreiskrankenhaus Langenau, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".